2025 Egyptian guidelines for the management of dyslipidemia.

ABSTRACT:

Background

The burden of premature atherosclerotic cardiovascular disease (ASCVD) in Egypt remains disproportionately high, and current international dyslipidemia guidelines have proven insufficient in achieving target lipid levels in the local population. This underscores the necessity for a context-specific national guideline. The 2025 Egyptian Guidelines for the Management of Dyslipidemia were developed through a structured consensus process led by an expert panel of cardiologists, endocrinologists, and representatives from national medical societies.

Main text

The methodology included two rounds of blind voting followed by a consensus meeting to ensure rigorous evaluation. The guidelines emphasize the importance of early detection of dyslipidemia through systematic scree

SUBMITTER: Reda A 

PROVIDER: S-EPMC12819915 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature